# Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Federal grant opportunity, via Kontrakk.

- **Agency:** National Institutes of Health
- **Opportunity number:** PAR-26-091
- **Status:** forecasted
- **Opens:** December 8, 2025
- **CFDA:** 93.394
- **View on Kontrakk:** https://kontrakk.com/grants/360946

## Description

No description provided.